Showing 561 - 580 results of 1,182 for search '"liver diseases"', query time: 0.09s Refine Results
  1. 561

    Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C by A. A. Konysheva, Ye. A. Saginova, S. V. Moiseyev, T. N. Krasnova, D. T. Abdurakhmanov

    Published 2012-11-01
    “…To study the functional changes of cardio-vascular system in patients with viral liver diseases.Material and methods. Overall 150 patients with hepatitis virus C-associated liver diseases, including 80 patients with chronic hepatitis and 70 – with liver cirrhosis (LC) have been included in original study. …”
    Get full text
    Article
  2. 562

    Role of HNF6 in liver homeostasis and pathophysiology by Miaomiao Tian, Weizhen Gao, Shujun Ma, Huiling Cao, Yu Zhang, Fuxiang An, Jianni Qi, Zhen Yang

    Published 2025-02-01
    “…We also highlight gaps in liver disease research and provide future research directions for the application of HNF6 and its downstream molecules as attractive targets in the treatment of liver diseases.…”
    Get full text
    Article
  3. 563
  4. 564
  5. 565

    The theses for MD degree by article Editorial

    Published 2014-11-01
    “…Schyokotova — Clinical and laboratory parameters and endothelial dysfunction at liver diseases, their diagnostic, prognostic value and potential of application for treatment response rate ratingA.A. …”
    Get full text
    Article
  6. 566
  7. 567

    Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling by Weidong Shao, Hui Xu, Kanghua Zeng, Mingzhou Ye, Renjun Pei, Kai Wang

    Published 2025-01-01
    “…The liver organoids also serve as ideal platforms for studying liver diseases such as hepatitis, liver fibrosis, viral liver diseases, and monogenic diseases. …”
    Get full text
    Article
  8. 568

    A 19-year-old Patient with Recurrent Pruritus and Jaundice by K. S. Nezhdanov, E. N. Shirokova, Yu. O. Shulpekova, A. S. Ostrovskaya, M. S. Zharkova, V. T. Ivashkin

    Published 2023-09-01
    “…Identification of etiology of cholestatic liver diseases requires broad differential diagnosis. …”
    Get full text
    Article
  9. 569

    Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells into Lymphocytes via ICAM-1 and LFA-1 Interaction by Deping Meng, Yuhong Qin, Nan Lu, Keke Fang, Yuan Hu, Zhigang Tian, Cai Zhang

    Published 2019-01-01
    “…These findings provide important insight into understanding liver extramedullary hematopoiesis and its significance, particularly under the state of some liver diseases, such as hepatitis, nonalcoholic fatty liver disease (NAFLD), and hepatocellular carcinoma (HCC).…”
    Get full text
    Article
  10. 570
  11. 571

    Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography by Hugo Perazzo, Valdilea G. Veloso, Beatriz Grinsztejn, Chris Hyde, Rodolfo Castro

    Published 2015-01-01
    “…Transient elastography (TE) based on liver stiffness measurement (LSM) is one of the most validated noninvasive methods for liver fibrosis staging in patients with chronic liver diseases. This method is painless, has no potential complications, is rapid (<10 min), and can be performed at the patient’s bedside. …”
    Get full text
    Article
  12. 572

    Kidney in systemic diseases by Marta Patricia Casanova González, David Rodríguez Zamora, Aldo Luis González Pérez

    Published 2007-06-01
    “…A review of the renal function alterant in congestive cardiac insufficiency and chronic liver diseases is carried out in this bibliographical revision. …”
    Get full text
    Article
  13. 573
  14. 574

    Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K/Akt Pathway by Ruonan Zhang, Xuewei Sun, Han Lu, Xinrui Zhang, Mingyan Zhang, Xuewen Ji, Xinyi Yu, Chengliang Tang, Zihan Wu, Yinghua Mao, Jin Zhu, Minjun Ji, Zhan Yang

    Published 2025-01-01
    “…The enterohepatic axis is one of the targets of recent attention due to its important role in liver diseases. Disulfiram (DSF) is a multitarget drug that has been proven to play a role in a variety of liver diseases and can affect intestinal flora, but whether it can alleviate ALI is not clear. …”
    Get full text
    Article
  15. 575

    Cell-Specific Regulation of Inflammatory Cytokines and Acute-Phase Proteins by the Glucocorticoid Receptor by Rebecca Winkler, Hong Lu

    Published 2023-01-01
    “…By specifically increasing GR activity in the liver, we may normalize chemokine imbalances and prevent sepsis in inflammatory liver diseases.…”
    Get full text
    Article
  16. 576

    A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024) by Minling Cao, Jiayi Zeng, Jiayu Wang, Junmin Jiang

    Published 2025-02-01
    “…Abstract Objective This study aimed to analyze the characteristics of patients undergoing percutaneous liver biopsies and investigate the pathological manifestations of four major liver diseases across different age groups. Methods A retrospective analysis was conducted of 4,717 liver pathology reports from 2009 to 2024. …”
    Get full text
    Article
  17. 577
  18. 578
  19. 579

    Liver Cell Death: Update on Apoptosis by Marc Bilodeau

    Published 2003-01-01
    “…Hepatocyte cell death is a cardinal feature of almost every liver disease. Apoptosis is a mode of cell death characterized by specific morphological and biochemical features. …”
    Get full text
    Article
  20. 580